WEGO Health launches online video venture

Share this article:
WEGO Health is launching an ad-supported online video network, dubbed WEGOHealth.tv, that will feature “conversation-style videos” featuring its medical subject matter expert “health activists,” each of whom reaches an audience of more than 15,000 a month.

WEGOHealth.tv's beta incarnation, which went live today, features video channels on MS, joint pain, breast cancer and diabetes.

“We are taking these health activists off their keyboards and onto the airwaves to amplify their voices and reach an even greater audience,” said WEGO CEO Jack Barrette.

WEGO aims to capitalize on increasing consumer health engagement through use of video, citing a recent Pew Research Center study showing that a quarter of Internet users have watched an online video on health or medical issues. Seven in ten of WEGO's health activists watch online videos about health topics and they are four times more likely to create and upload their own health videos than the average online consumer, said the venture.

“Videos allow health activists and community leaders to really show the passion behind their message and connect with their audience in an even more personal way,” said WEGO health activist and ChronicBabe.com blogger Jenni Prokopy.

Paid advertising and content will be clearly marked, the company said, and all video editorial decisions will be independent of sponsor control.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...